InMed Pharmaceuticals
Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a...
Read moreInvestor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a...
Read moreAstral Resources (AAR:AU) has announced Theia In-fill – Multiple High-Grade Zones of Gold Download the PDF here. This post appeared...
Read moreGreen Technology Metals(GT1:AU) has announced Ontario Lithium Project Development Update Download the PDF here. This post appeared first on investingnews.com
Read moreGraphite One (TSXV:GPH,OTCQX:GPHOF) announced on November 13 that it has identified rare earth elements (REEs) at its Graphite Creek deposit,...
Read moreResearchers have documented the first known recovery of naturally formed nanoscale monazite from a living plant, potentially opening up new...
Read more